Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Acceleron Pharma Inc. (XLRN)

41.175   0.635 (1.57%) 04-25 15:57
Open: 40.31 Pre. Close: 40.54
High: 41.3 Low: 39.995
Volume: 94,950 Market Cap: 2169M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 41.795 - 42.034 42.034 - 42.251
Low: 39.974 - 40.233 40.233 - 40.466
Close: 40.17 - 40.582 40.582 - 40.955

Technical analysis

as of: 2019-04-25 3:34:12 PM
Overall:       
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 51.97     One year: 56.19
Support: Support1: 38.65    Support2: 32.16
Resistance: Resistance1: 44.50    Resistance2: 48.11
Pivot: 42.80
Moving Average: MA(5): 40.57     MA(20): 43.72
MA(100): 44.30     MA(250): 45.32
MACD: MACD(12,26): -1.25     Signal(9): -0.87
Stochastic oscillator: %K(14,3): 26.28     %D(3): 22.44
RSI: RSI(14): 40.64
52-week: High: 59.59  Low: 32.53  Change(%): 10.8
Average Vol(K): 3-Month: 36996  10-Days: 31856

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
XLRN has closed above bottom band by 30.0%. Bollinger Bands are 24.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 18 Apr 2019 16:10:21 Z
First Week of November 15th Options Trading For Acceleron Pharma (XLRN)

Tue, 09 Apr 2019 00:07:30 Z
Celgene & Acceleron Submit BLA for Luspatercept to the FDA

Thu, 21 Mar 2019 22:06:44 Z
Bullish Two Hundred Day Moving Average Cross - XLRN

Thu, 28 Feb 2019 09:08:37 Z
Acceleron Pharma (XLRN) Q4 2018 Earnings Conference Call Transcript

Wed, 20 Feb 2019 20:10:07 Z
Is Acceleron Pharma a Buy?

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 52.49
Shares Float (M) 51.52
% Held by Insiders
% Held by Institutions 138.50
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -2.590
EPS Est. Current Year -2.690
EPS Est. Next Year -2.280
EPS Est. Next Quarter -0.640
Forward EPS -1.890
Book Value (p.s.) 8.430
PEG Ratio
Profit Margin
Operating Margin -889.24
Return on Assets (ttm) -34.6
Return on Equity (ttm) -37.0
Qtrly Rev. Growth 3.0
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -94.71
Levered Free Cash Flow (M) -56.55

Stock Valuations

P/E -15.84
P/E Growth Ratio 0.01
P/BV 4.87
P/S 6839754240.00
P/CF -22.74

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.